BLA is delayed, HIV not approved (I know very unli

Quote:

---

BLA is delayed, HIV not approved (I know very unlikely) and we retrace to 50-60c or a lot deeper and gains are (partly) gone.

---

I wouldn't trust the FDA to not screw us over again. With our constant talks with the FDA and giving them what they ask for I can't see any cause for delay. For CMC our first in line manufacturer has a trial CMC already in place so that should be a go.

If there is a BLA delay your retrace might be right. Possibly stay a bit higher as more investors learn about us. But all that will do is delay the ultimate rise in stock price. In this case a wait on the rise in share price is better than losing out on it. The potential with this company is unlike anything I've ever seen and I'm not going to lose any of that potential by selling early.

A very long time ago when I started trading and I was trading on the lows and bounces I would get jittery on the upswings trying to time it right. Then I learned to relax and give up a few percent and sell on the downside. When I switched solely to biopharma I had to change my whole mindset and look at the long term.

Not approved for HIV? We have 5+ years of data proving it out in combo and monotherapy.